Potential biomarkers for lung adenocarcinoma identified by integrative transcriptomics analysis

Abstract

Lung cancer is one of the most occurring and death-causing cancers worldwide. Despite the progress, survival rate is still low due to the late diagnosis. The aim of this study is to develop a computational framework to identify potential prognostic biomarkers for lung adenocarcinoma (LUAD). Gene expression profiles obtained from three independent studies were analyzed to find differentially expressed genes (DEGs) in LUAD. Disease-specific protein-protein interaction (PPI) network was constructed among common DEGs and hub proteins were identified. Gene expression data was integrated with the human transcriptional regulatory network (TRN) to identify key regulatory elements and construct disease-specific TRN. Hub proteins that were also present in TRN of LUAD were considered as potential biomarkers and assessed by survival analysis. AURKA, CAV1, CLU, ENO1, FHL1, FHL2, LMO2, MYH11, NME1 and SFN were discovered as biomarkers for LUAD and survival analysis not only indicated their significant prognostic performance as a group but also revealed their contribution to the discrimination of risk groups. Our findings suggested that identified biomarkers could be valuable in LUAD progression and they should be considered for further experimentation.

Keywords

• Lung adenocarcinoma
• Transcriptome profiling
• Network reconstruction
• Potential biomarkers
• Survival analysis

References

1. guirre-Gamboa, R., Gomez-Rueda, H., Martínez-Ledesma, E., Martínez-Torteya, A., Chacolla-Huaringa, R., Rodriguez-Barrientos, A., Tamez-Peña, J. G., & Treviño, V. (2013). SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis. PLoS ONE, 8(9), 1–9. https://doi.org/10.1371/journal.pone.0074250
2. Benjamini, Y., & Hochberg, Y. (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological), 57(1), 289–300.
3. Bolstad, B. M., Irizarry, R. A., Astrand, M., & Speed, T. P. (2003). A Comparison of Normalization Methods for High Density Oligonucleotide Array Data based on Variance and Bias. Bioinformatics, 19(2), 185–193. http://www.ncbi.nlm.nih.gov/pubmed/12538238
4. Bovolenta, L. A., Acencio, M. L., & Lemke, N. (2012). HTRIdb: an open-access database for experimentally verified human transcriptional regulation interactions. BMC Genomics, 13(405). https://doi.org/10.1186/1471-2164-13-405
5. Cagle, P. T., Allen, T. C., & Olsen, R. J. (2013). Lung cancer biomarkers: present status and future developments. Archives of Pathology & Laboratory Medicine, 137(9), 1191–1198. https://doi.org/10.5858/arpa.2013-0319-CR
6. Cao, C. Y., Mok, S. W.-F., Cheng, V. W.-S., & Tsui, S. K.-W. (2015). The FHL2 Regulation in the Transcriptional Circuity of Human Cancers. Gene, 572(1), 139–148. https://doi.org/10.1016/j.physbeh.2017.03.040
7. Chin, C. H., Chen, S. H., Wu, H. H., Ho, C. W., Ko, M. T., & Lin, C. Y. (2014). cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Systems Biology, 8 (Suppl 4(511), 1–7. https://doi.org/10.1186/1752-0509-8-S4-S11
8. Chou, C. H., Shrestha, S., Yang, C. D., Chang, N. W., Lin, Y. L., Liao, K. W., Huang, W. C., Sun, T. H., Tu, S. J., Lee, W. H., Chiew, M. Y., Tai, C. S., Wei, T. Y., Tsai, T. R., Huang, H. T., Wang, C. Y., Wu, H. Y., Ho, S. Y., Chen, P. R., … & Huang, H. Da. (2018). MiRTarBase update 2018: A resource for experimentally validated microRNA-target interactions. Nucleic Acids Research, 46(D1), D296–D302. https://doi.org/10.1093/nar/gkx1067

9. Cieślik, M., & Chinnaiyan, A. M. (2018). Cancer transcriptome profiling at the juncture of clinical translation. Nature Reviews Genetics, 19(2), 93–109. https://doi.org/10.1038/nrg.2017.96
10. Ding, L., Wang, Z., Yan, J., Yang, X., Liu, A., Qiu, W., Zhu, J., Han, J., Zhang, H., Lin, J., Cheng, L., Qin, X., Niu, C., Yuan, B., Wang, X., Zhu, C., Zhou, Y., Li, J., Song, H., … & Ye, Q. (2009). Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-β-like signaling pathway. Journal of Clinical Investigation, 119(2), 349–361. https://doi.org/10.1172/JCI35930
11. Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. a. (2004). Affy-Analysis of Affymetrix GeneChip Data at the Probe Level. Bioinformatics, 20(3), 307–315. https://doi.org/10.1093/bioinformatics/btg405
12. Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., Hornik, K., Hothorn, T., Huber, W., Iacus, S., Irizarry, R., Leisch, F., Li, C., Maechler, M., Rossini, A. J., … & Zhang, J. (2004). Bioconductor: Open Software Development for Computational Biology and Bioinformatics. Genome Biol, 5(10), R80. https://doi.org/10.1186/gb-2004-5-10-r80
13. Girard, L., Rodriguez-Canales, J., Behrens, C., Thompson, D. M., Botros, I. W., Tang, H., Xie, Y., Rekhtman, N., Travis, W. D., Wistuba, I. I., Minna, J. D., & Gazdar, A. F. (2017). An Expression Signature as an Aid to the Histologic Classification of Non-Small Cell Lung Cancer. Clin Cancer Res., 22(19), 4880–4889. https://doi.org/10.1158/1078-0432.CCR-15-2900.An
14. Gov, E., Kori, M., & Arga, K. Y. (2017). Multiomics Analysis of Tumor Microenvironment Reveals Gata2 and miRNA-124-3p as Potential Novel Biomarkers in Ovarian Cancer. OMICS A Journal of Integrative Biology, 21(10), 603–615. https://doi.org/10.1089/omi.2017.0115
15. Habiel, D. M., Camelo, A., Espindola, M., Burwell, T., Hanna, R., Miranda, E., Carruthers, A., Bell, M., Coelho, A. L., Liu, H., Pilataxi, F., Clarke, L., Grant, E., Lewis, A., Moore, B., Knight, D. A., Hogaboam, C. M., & Murray, L. A. (2017). Divergent roles for Clusterin in Lung Injury and Repair. Scientific Reports, 7(15444), 1–14. https://doi.org/10.1038/s41598-017-15670-5
16. Han, H., Cho, J. W., Lee, S., Yun, A., Kim, H., Bae, D., Yang, S., Kim, C. Y., Lee, M., Kim, E., Lee, S., Kang, B., Jeong, D., Kim, Y., Jeon, H. N., Jung, H., Nam, S., Chung, M., Kim, J. H., & Lee, I. (2018). TRRUST v2: An expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Research, 46(D1), D380–D386. https://doi.org/10.1093/nar/gkx1013
17. Jeffery, T. K., & Wanstall, J. C. (2001). Pulmonary vascular remodeling: A target for therapeutic intervention in pulmonary hypertension. Pharmacology and Therapeutics, 92(1), 1–20. https://doi.org/10.1016/S0163-7258(01)00157-7
18. Kamburov, A., Stelzl, U., Lehrach, H., & Herwig, R. (2013). The ConsensusPathDB interaction database: 2013 Update. Nucleic Acids Research, 41(Database Issue), D793–D800. https://doi.org/10.1093/nar/gks1055
19. Li, Z., Sang, M., Tian, Z., Liu, Z., Lv, J., Zhang, F., & Shan, B. (2019). Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis. Oncology Letters, 18, 4429–4440. https://doi.org/10.3892/ol.2019.10796
20. Liu, X., Meng, L., Li, J., Meng, J., Teng, X., Gu, H., Hu, S., & Wei, Y. (2015). Secretory clusterin is upregulated in rats with pulmonary arterial hypertension induced by systemic-to-pulmonary shunts and exerts important roles in pulmonary artery smooth muscle cells. Acta Physiologica, 213(2), 505–518. https://doi.org/10.1111/apha.12352
21. Lo Iacono, M., Monica, V., Saviozzi, S., Ceppi, P., Bracco, E., Papotti, M., & Scagliotti, G. V. (2011). Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation. Journal of Translational Medicine, 9(100), 1–6. https://doi.org/10.1186/1479-5876-9-100
22. Lu, M., Zhang, Q., Deng, M., Miao, J., Guo, Y., Gao, W., & Cui, Q. (2008). An analysis of human microRNA and disease associations. PLoS ONE, 3(10), 1–5. https://doi.org/10.1371/journal.pone.0003420
23. Macedo, F., Ladeira, K., Pinho, F., Saraiva, N., Bonito, N., Pinto, L., & Gonçalves, F. (2017). Bone metastases: An overview. Oncology Reviews, 11(321), 43–49. https://doi.org/10.4081/oncol.2017.321
24. Marino, N., Marshall, J.-C., Collins, J. W., Zhou, M., Qian, Y., Veenstra, T., & Steeg, P. S. (2013). Nm23-H1 binds gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis. Cancer Res., 73(19), 1–23. https://doi.org/10.1038/jid.2014.371
25. Matthews, J. M., Lester, K., Joseph, S., & Curtis, D. J. (2013). LIM-domain-only proteins in cancer. Nature Reviews Cancer, 13(2), 111–122. https://doi.org/10.1038/nrc3418
26. Nie, M. J., Pan, X. T., Tao, H. Y., Xu, M. J., Liu, S. L., Sun, W., Wu, J., & Zou, X. (2020). Clinical and prognostic significance of MYH11 in lung cancer. Oncology Letters, 19(6), 3899–3906. https://doi.org/10.3892/ol.2020.11478
27. Otálora-Otálora, B. A., Florez, M., López-Kleine, L., Canas Arboleda, A., Grajales Urrego, D. M., & Rojas, A. (2019). Joint Transcriptomic Analysis of Lung Cancer and Other Lung Diseases. Frontiers in Genetics, 10(December), 1–18. https://doi.org/10.3389/fgene.2019.01260
28. Patel, J. N., Ersek, J. L., & Kim, E. S. (2015). Lung cancer biomarkers, targeted therapies and clinical assays. Transl Lung Cancer Res, 4(5), 503–514.
29. Pullamsetti, S. S., Kojonazarov, B., Storn, S., Gall, H., Salazar, Y., Wolf, J., Weigert, A., El-Nikhely, N., Ghofrani, H. A., Krombach, G. A., Fink, L., Gattenlöhner, S., Rapp, U. R., Schermuly, R. T., Grimminger, F., Seeger, W., & Savai, R. (2017). Lung cancer-associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-talk. Science Translational Medicine, 9(416), 1–16. https://doi.org/10.1126/scitranslmed.aai9048
30. R Core Team. (2020). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.r-project.org/index.html
31. Robles, A. I., Arai, E., Mathé, E. A., Okayama, H., Schetter, A. J., Brown, D., Petersen, D., Bowman, E. D., Noro, R., Welsh, J. A., Edelman, D. C., Stevenson, H. S., Wang, Y., Tsuchiya, N., Kohno, T., Skaug, V., Mollerup, S., Haugen, A., Meltzer, P. S., … & Harris, C. C. (2016). An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma based on mRNA, microRNA and DNA Methylation Biomarkers. J Thorac Oncol, 10(7), 1037–1048. https://doi.org/10.1097/JTO.0000000000000560.An
32. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003). Cytoscape : A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res, 13(11), 2498–2504. https://doi.org/10.1101/gr.1239303.metabolite
33. Shi, Y. B., Li, J., Lai, X. N., Jiang, R., Zhao, R. C., & Xiong, L. X. (2020). Multifaceted roles of caveolin-1 in lung cancer: A new investigation focused on tumor occurrence, development and therapy. Cancers, 12, 1–19. https://doi.org/10.3390/cancers12020291
34. Shiba-Ishii, A., Kim, Y., Shiozawa, T., Iyama, S., Satomi, K., Kano, J., Sakashita, S., Morishita, Y., & Noguchi, M. (2015). Stratifin accelerates progression of lung adenocarcinoma at an early stage. Molecular Cancer, 14(142), 1–6. https://doi.org/10.1186/s12943-015-0414-1
35. Smyth, G. K. (2004). Linear models and empirical Bayes methods for assessing diferential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology, 3(1), article 3. https://doi.org/10.2202/1544-6115.1027
36. Stark, C., Breitkreutz, B.-J., Reguly, T., Boucher, L., Breitkreutz, A., & Tyers, M. (2006). BioGRID: a general repository for interaction datasets. Nucleic Acids Res, 34(Database issue), D535-539. https://doi.org/10.1093/nar/gkj109
37. Tang, A., Gao, K., Chu, L., Zhang, R., Yang, J., & Zheng, J. (2017). Aurora kinases: Novel therapy targets in cancers. Oncotarget, 8(14), 23937–23954. https://doi.org/10.18632/oncotarget.14893
38. Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L., Bidkhori, G., Benfeitas, R., Arif, M., Liu, Z., Edfors, F., Sanli, K., Von Feilitzen, K., Oksvold, P., Lundberg, E., Hober, S., Nilsson, P., Mattsson, J., Schwenk, J. M., Brunnström, H., … & Ponten, F. (2017). A pathology atlas of the human cancer transcriptome. Science, 357(eaan2507),1–11. https://doi.org/10.1126/science.aan2507
39. Villalobos, P., & Wistuba, I. I. (2017). Lung Cancer Biomarkers. Hematol Oncol Clin North Am., 31(1), 13–29. https://doi.org/10.1016/j.hoc.2016.08.006.Lung
40. Willuda, J., Linden, L., Lerchen, H. G., Kopitz, C., Stelte-Ludwig, B., Pena, C., Lange, C., Golfier, S., Kneip, C., Carrigan, P. E., McLean, K., Schuhmacher, J., Von Ahsen, O., Müller, J., Dittmer, F., Beier, R., El Sheikh, S., Tebbe, J., Leder, G., … & Kreft, B. (2017). Preclinical antitumor efficacy of BAY 1129980-a novel auristatin-based anti-C4.4A (LYPD3) antibody-drug conjugate for the treatment of non-small cell lung cancer. Molecular Cancer Therapeutics, 16(5), 893–904. https://doi.org/10.1158/1535-7163.MCT-16-0474
41. Xiao, F., Zuo, Z., Cai, G., Kang, S., Gao, X., & Li, T. (2009). miRecords: An integrated resource for microRNA-target interactions. Nucleic Acids Research, 37(Database issue), D105–D110. https://doi.org/10.1093/nar/gkn851
42. Xu, Lai, Wang, R., Ziegelbauer, J., Wu, W. W., Shen, R. F., Juhl, H., Zhang, Y., Pelosof, L., & Rosenberg, A. S. (2017). Transcriptome analysis of human colorectal cancer biopsies reveals extensive expression correlations among genes related to cell proliferation, lipid metabolism, immune response and collagen catabolism. Oncotarget,8(43),74703–74719. https://doi.org/10.18632/oncotarget.20345
43. Xu, Liyun, Lu, C., Huang, Y., Zhou, J., Wang, X., Liu, C., Chen, J., & Le, H. (2018). SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker. BMB Reports, 51(12), 648–653. https://doi.org/10.5483/BMBRep.2018.51.12.205
44. Xu, S., Xu, H., Wang, W., Li, S., Li, H., Li, T., Zhang, W., Yu, X., & Liu, L. (2019). The role of collagen in cancer: From bench to bedside. Journal of Translational Medicine, 17(1), 1–22. https://doi.org/10.1186/s12967-019-2058-1
45. Yan, Y., Xu, Z., Qian, L., Zeng, S., Zhou, Y., Chen, X., Wei, J., & Gong, Z. (2019). Identification of CAV1 and DCN as potential predictive biomarkers for lung adenocarcinoma. American Journal of Physiology - Lung Cellular and Molecular Physiology, 316(4), L630–L643. https://doi.org/10.1152/ajplung.00364.2018
46. Zhang, L., Wang, H., & Dong, X. (2018). Diagnostic value of α-enolase expression and serum α-enolase autoantibody levels in lung cancer. Jornal Brasileiro de Pneumologia, 44(1), 18–23. https://doi.org/10.1590/s1806-37562016000000241
47. Zhang, Y., Foreman, O., Wigle, D., Kosari, F., Vasmatzis, G., Salisbury, J., van Deursen, J., & Galardy, P. (2012). USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis. Journal of Clinical Investigation, 122(12), 4362–4374. https://doi.org/10.1172/JCI63084DS1